T

Trulieve Cannabis Corp
CNSX:TRUL

Watchlist Manager
Trulieve Cannabis Corp
CNSX:TRUL
Watchlist
Price: 16.38 CAD -0.73% Market Closed
Market Cap: 3.1B CAD
Have any thoughts about
Trulieve Cannabis Corp?
Write Note

Relative Value

The Relative Value of one TRUL stock under the Base Case scenario is 23.67 CAD. Compared to the current market price of 16.38 CAD, Trulieve Cannabis Corp is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TRUL Relative Value
Base Case
23.67 CAD
Undervaluation 31%
Relative Value
Price
T
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
58
Median 3Y
1.7
Median 5Y
3.3
Industry
2.6
Forward
1.8
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-1.1
Industry
22.3
Forward
-29.5
vs History
68
vs Industry
45
Median 3Y
6.5
Median 5Y
32.6
Industry
17.5
vs History
25
vs Industry
6
Median 3Y
-13.5
Median 5Y
-5.5
Industry
24.8
vs History
55
vs Industry
51
Median 3Y
1.3
Median 5Y
1.8
Industry
2.1
vs History
66
vs Industry
51
Median 3Y
2.2
Median 5Y
3.7
Industry
2.7
Forward
2.1
vs History
69
vs Industry
51
Median 3Y
4
Median 5Y
4.9
Industry
5.3
vs History
66
vs Industry
38
Median 3Y
8.8
Median 5Y
9.7
Industry
13.4
Forward
6.4
vs History
57
vs Industry
22
Median 3Y
20
Median 5Y
17.9
Industry
16.8
Forward
14.6
vs History
71
vs Industry
43
Median 3Y
7.8
Median 5Y
33.1
Industry
15.9
vs History
14
vs Industry
31
Median 3Y
-9.5
Median 5Y
-14.3
Industry
18.5
vs History
55
vs Industry
59
Median 3Y
0.9
Median 5Y
1.3
Industry
1.9

Multiples Across Competitors

TRUL Competitors Multiples
Trulieve Cannabis Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Trulieve Cannabis Corp
CNSX:TRUL
3.1B CAD 1.9 -23.5 8 16.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
793.7B USD 20.4 108.1 54.1 60.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.1 37.5 25 28.7
US
Johnson & Johnson
NYSE:JNJ
385.5B USD 4.4 26.3 12.7 16.5
US
Merck & Co Inc
NYSE:MRK
260.6B USD 4.2 19 12.9 15.8
CH
Roche Holding AG
SIX:ROG
213.6B CHF 3.6 18.6 10.4 12.4
UK
AstraZeneca PLC
LSE:AZN
171.2B GBP 4.5 34.5 170.6 255.7
CH
Novartis AG
SIX:NOVN
183.5B CHF 4.3 13.1 10.4 15.4
US
Pfizer Inc
NYSE:PFE
161.4B USD 2.7 38 11.1 16.7
P/E Multiple
Earnings Growth
US
T
Trulieve Cannabis Corp
CNSX:TRUL
Average P/E: 36.9
Negative Multiple: -23.5
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
108.1
454%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
37.5
89%
US
Johnson & Johnson
NYSE:JNJ
26.3
-22%
US
Merck & Co Inc
NYSE:MRK
19
7 426%
CH
Roche Holding AG
SIX:ROG
18.6
30%
UK
AstraZeneca PLC
LSE:AZN
34.5
175%
CH
Novartis AG
SIX:NOVN
13.1
19%
US
Pfizer Inc
NYSE:PFE
38
712%

See Also

Discover More
Back to Top